Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AOC3 | Q16853 | 18/20 | 0.68 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16047677 | 0.85 | AOC3 (0.82) | AOC3KCNH2 | |
| SCHEMBL30026182 | 0.85 | AOC3 (0.82) | AOC3KCNH2 | |
| SCHEMBL30026425 | 0.81 | AOC3 (1.00) | AOC3KCNH2 | |
| SCHEMBL16048595 | 0.81 | AOC3 (1.00) | AOC3KCNH2 | |
| SCHEMBL16052787 | 0.71 | AOC3 (1.00) | AOC3KCNH2 | |
| SCHEMBL16052882 | 0.70 | KCNH2 (0.68) | AOC3KCNH2 | |
| SCHEMBL16053138 | 0.70 | AOC3 (1.00) | AOC3KCNH2 | |
| SCHEMBL16067936 | 0.67 | AOC3 (0.84) | AOC3KCNH2 | |
| SCHEMBL25310063 | 0.67 | AOC3 (0.44) | AOC3 | |
| SCHEMBL19117494 | 0.67 | AOC3 (0.49) | AOC3KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200262835-A1 | COMPOUNDS | PROXIMAGEN, LLC (US) | 2020-08-20 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200262835-A1 | COMPOUNDS | QSOX1, AOX1, EPX | AOC3 27/4885KCNH2 642/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.